Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Caredx Inc (NASDAQ: CDNA) closed at $16.31 in the last session, down -2.80% from day before closing price of $16.78. In other words, the price has decreased by -$2.80 from its previous closing price. On the day, 0.98 million shares were traded. CDNA stock price reached its highest trading level at $16.89 during the session, while it also had its lowest trading level at $16.125.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.62. For the most recent quarter (mrq), Quick Ratio is recorded 2.75 and its Current Ratio is at 3.03. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
On January 15, 2025, Wells Fargo Upgraded its rating to Equal Weight which previously was Underweight and also lowered its target price recommendation from $28 to $24.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.Wells Fargo initiated its Underweight rating on August 28, 2024, with a $28 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 07 ’25 when Novack Jeffrey Adam sold 2,688 shares for $15.52 per share. The transaction valued at 41,723 led to the insider holds 105,218 shares of the business.
Jeffrey Adam Novack bought 2,688 shares of CDNA for $40,347 on Nov 07 ’25. On Nov 05 ’25, another insider, ABHISHEK JAIN, who serves as the Officer of the company, bought 53,388 shares for $15.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 838866304 and an Enterprise Value of 672293312. As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 2.69. Its current Enterprise Value per Revenue stands at 1.878 whereas that against EBITDA is -45.822.
Stock Price History:
The Beta on a monthly basis for CDNA is 2.55, which has changed by -0.22134572 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $26.37, while it has fallen to a 52-week low of $10.96. The 50-Day Moving Average of the stock is 10.78%, while the 200-Day Moving Average is calculated to be -3.60%.
Shares Statistics:
According to the various share statistics, CDNA traded on average about 1.34M shares per day over the past 3-months and 1529550 shares per day over the past 10 days. A total of 51.41M shares are outstanding, with a floating share count of 48.55M. Insiders hold about 5.61% of the company’s shares, while institutions hold 103.39% stake in the company. Shares short for CDNA as of 1761868800 were 6568572 with a Short Ratio of 4.90, compared to 1759190400 on 6243995. Therefore, it implies a Short% of Shares Outstanding of 6568572 and a Short% of Float of 13.08.
Earnings Estimates
The performance of Caredx Inc (CDNA) in the stock market is under the watchful eye of 3.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $0.19, with high estimates of $0.22 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.72 and $0.67 for the fiscal current year, implying an average EPS of $0.7. EPS for the following year is $0.84, with 6.0 analysts recommending between $1.1 and $0.73.
Revenue Estimates
According to 8 analysts,. The current quarter’s revenue is expected to be $102.57M. It ranges from a high estimate of $103.9M to a low estimate of $101.76M. As of. The current estimate, Caredx Inc’s year-ago sales were $86.58MFor the next quarter, 8 analysts are estimating revenue of $100.77M. There is a high estimate of $102.28M for the next quarter, whereas the lowest estimate is $97.8M.
A total of 5 analysts have provided revenue estimates for CDNA’s current fiscal year. The highest revenue estimate was $374.5M, while the lowest revenue estimate was $373.4M, resulting in an average revenue estimate of $373.91M. In the same quarter a year ago, actual revenue was $333.79MBased on 8 analysts’ estimates, the company’s revenue will be $415.92M in the next fiscal year. The high estimate is $428.3M and the low estimate is $394.4M.
